Summary of Purpose
Stroke is a leading cause of morbidity and mortality.Acute ischemia causes irreversible damage to neurons and glial cells, leading to functional deficits and chronic sequelae with variable degrees of spontaneous recovery of function. Stem cells have been shown to enhance recovery through multiple immunomodulatory effects, neoangiogenesis and neurogenesis. We conducted a prospective randomised end observer...Read More →
The following dates are available for this trial. Trial information last updated on 14 March 2017.
|1 Jul 2015||7 Mar 2017||1 Dec 2016||1 Dec 2016||1 Mar 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|